GLP-1 Weight Loss Drugs Reshape Obesity Care In South Africa
GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers.
Lilly Hits $1 Trillion Valuation with Weight-Loss Success
Eli Lilly hits $1 trillion valuation, marking a historic milestone in the pharmaceutical industry with successful weight-loss drugs.
A decade of transformation in obesity treatment
ObesityWeek 2024 attracted unprecedented attention from Wall Street, highlighting obesity treatment's booming pharmaceutical industry.
Medicines seized amidst surge in demand for Ozempic copies
New Zealand customs has seized semaglutide-based drugs made in Bangladesh, underscoring a rise in global demand for cheaper alternatives to Ozempic.
As competition heats up, Novo Nordisk’s share price declines
Novo Nordisk's share price dropped 19% amidst growing competition from Eli Lilly in the diabetes and weight-loss drug market.